Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Zions Bancorporation N.A.

Zions Bancorporation N.A. increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 7.0% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 12,391 shares of the medical equipment provider's stock after purchasing an additional 814 shares during the quarter. Zions Bancorporation N.A.'s holdings in Intuitive Surgical were worth $6,468,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently added to or reduced their stakes in ISRG. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth $25,000. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical during the 4th quarter valued at about $26,000. BankPlus Trust Department acquired a new stake in Intuitive Surgical in the 4th quarter valued at about $28,000. Kohmann Bosshard Financial Services LLC purchased a new position in Intuitive Surgical in the 4th quarter worth approximately $31,000. Finally, Decker Retirement Planning Inc. acquired a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $36,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Down 3.4 %

ISRG stock traded down $17.44 during midday trading on Friday, hitting $490.47. The company's stock had a trading volume of 1,073,026 shares, compared to its average volume of 1,522,095. The firm has a 50-day simple moving average of $558.29 and a 200-day simple moving average of $532.25. The firm has a market capitalization of $174.69 billion, a P/E ratio of 76.51, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00.

Remove Ads

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the company. Bernstein Bank lifted their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the stock an "overweight" rating in a research report on Monday, January 27th. Robert W. Baird lowered their price target on shares of Intuitive Surgical from $707.00 to $600.00 and set an "outperform" rating on the stock in a research report on Tuesday, March 18th. Stifel Nicolaus raised their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a "buy" rating in a research report on Thursday, December 5th. Truist Financial decreased their target price on shares of Intuitive Surgical from $666.00 to $605.00 and set a "buy" rating on the stock in a report on Monday, March 17th. Finally, Evercore ISI raised their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $611.86.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the sale, the executive vice president now directly owns 5,224 shares of the company's stock, valued at $2,607,925.28. The trade was a 68.85 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Jamie Samath sold 269 shares of the stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the transaction, the chief financial officer now owns 3,282 shares in the company, valued at approximately $1,936,380. The trade was a 7.58 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 33,754 shares of company stock worth $17,691,621. Company insiders own 0.90% of the company's stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.